Why Your Wegovy Weight Loss Has Stalled — and What Actually Helps

You've been doing everything right, so why has the weight stopped?

Picture this: for the first two months on Wegovy, the scale moved reliably. You felt less hungry, portions felt easier to manage, and the weekly weigh-ins felt like confirmation you were on the right track. Then, somewhere around month three or four, the movement slowed to a crawl and then stopped altogether. The number on the scale sits there, unmoved, and the question starts to form: has Wegovy stopped working for me?

Almost certainly not. What you're experiencing is one of the most consistent features of weight-loss treatment: a metabolic plateau. When body weight falls, the body reduces the energy it burns at rest, a well-documented adaptive response that has nothing to do with willpower or effort. This happens with every form of weight management, from dietary changes alone to medically supervised programmes. Semaglutide, the active ingredient in Wegovy, continues to act on GLP-1 receptors in the brain and gut throughout treatment; a stall doesn't mean the drug has become inactive.

The NHS semaglutide patient page notes that weight loss is typically gradual and that the medicine works alongside a reduced-calorie diet and increased activity, both of which may need revisiting when progress levels off. It's also worth remembering that the STEP 1 trial, published in the New England Journal of Medicine, measured results over 68 weeks; meaningful weight loss continued well past the early months for many participants. A stall at week 14 is not the same thing as the treatment ending.

The specific reasons a Wegovy weight stall tends to happen

Several factors tend to converge around the time a stall appears, and most of them are at least partly addressable.

Dose stage plays a bigger role than many people realise. Wegovy is titrated gradually, starting at 0.25mg and working up over several months toward the 2.4mg maintenance dose. At lower doses, the appetite-suppressing effect is milder by design; a stall during early titration may simply reflect that the therapeutic dose hasn't been reached yet. Your prescriber decides when and whether a dose increase is appropriate, taking your response and tolerability into account. If you're not sure how long Wegovy typically takes to work at each stage, that context can help you read your own timeline more accurately.

Beyond dose, three things repeatedly show up in people who break through a plateau: protein intake, strength-based activity and sleep. When appetite falls on semaglutide, it becomes easy to under-eat protein in particular, and inadequate protein accelerates muscle loss, which in turn slows metabolic rate. Staying well hydrated and prioritising seven to nine hours of sleep are not lifestyle-magazine advice; both genuinely affect the hormones that regulate hunger and fat storage. A conversation with a dietitian can be useful here.

It is also worth keeping a practical eye on portion creep. Wegovy reduces appetite strongly in the early weeks; as your body adapts, hunger signals can gradually reassert themselves. The pen that lives in your fridge door is doing its job, but if meals have quietly grown back toward their old size, the calorie balance shifts. Tracking food for a week, even roughly, can reveal whether this is happening.

When a stall on Wegovy signals something to discuss with your prescriber

A short plateau (a week or two of flat progress) is almost always normal, particularly around a dose transition. If you want to understand the full picture of what drives stalled weight loss on Wegovy and how to interpret it clinically, that detail can help you have a more informed conversation with your prescriber. A stall on Wegovy that persists for four to six weeks, despite no obvious change in diet or activity, is worth raising with a clinician. There are several things a prescriber might consider: whether you're at the right dose for your stage of treatment, whether a weight-related condition such as an underactive thyroid is affecting progress, or whether the overall programme needs adjusting.

NICE's guidance on semaglutide (TA875) includes a benchmark that clinicians use: if a person has lost less than five per cent of their starting weight after six months at the maintenance dose, that's a prompt to review whether continuing is appropriate. This isn't a threat, it's a clinical checkpoint designed to make sure treatment is genuinely working for each individual. You can read more about what to do if Wegovy isn't producing weight loss and the factors clinicians look at in that situation.

For those wondering whether their experience is a stall or something more persistent, reading about the typical weight loss pattern on Wegovy across a full course of treatment gives useful perspective. Progress is rarely linear, the overall trend over months matters more than any individual week. If you want to understand more about the full picture of how Wegovy works as a licensed treatment, that sits alongside all the practical detail.

Practical steps that genuinely help break a weight stall

None of the following replaces a conversation with your prescriber, but they are grounded in what the clinical evidence supports alongside GLP-1 treatment.

First, revisit the basics honestly. Are meals genuinely smaller than before treatment, or have portions drifted? Is protein making up a reasonable share of each meal? Aim for sources such as chicken, fish, eggs, legumes and low-fat dairy at every eating occasion. Second, if activity has been mainly walking or cardio, adding two sessions of resistance training per week helps preserve lean mass during a calorie deficit, and lean mass determines how quickly the body burns energy at rest. Third, if sleep is consistently under seven hours, addressing that is not optional: NHS guidance on healthy weight acknowledges sleep as a genuine factor in weight regulation, not just background noise.

It is also worth revisiting whether a weight stall is actually a stall. Body composition can shift (fat reducing while lean tissue or fluid temporarily increases) without the scale reflecting it. Measurements of waist circumference or how clothing fits can tell a different story. Some people find that the experience of stalling on Wegovy is shorter than it felt week to week once they look back at the overall curve.

If you're considering your options or want a clinical eye on where you are in treatment, starting a free consultation lets our prescribers review your situation properly and advise on the most appropriate next step.